160 related articles for article (PubMed ID: 12699438)
1. Oral administration of the growth hormone secretagogue NN703 in adult patients with growth hormone deficiency.
Svensson J; Monson JP; Vetter T; Hansen TK; Savine R; Kann P; Bex M; Reincke M; Hagen C; Beckers A; Ilondo MM; Zdravkovic M; Bengtsson BA; Korbonits M;
Clin Endocrinol (Oxf); 2003 May; 58(5):572-80. PubMed ID: 12699438
[TBL] [Abstract][Full Text] [Related]
2. The pharmacokinetics, pharmacodynamics, safety and tolerability of a single dose of NN703, a novel orally active growth hormone secretagogue in healthy male volunteers.
Zdravkovic M; Søgaard B; Ynddal L; Christiansen T; Agersø H; Thomsen MS; Falch JE; Ilondo MM
Growth Horm IGF Res; 2000 Aug; 10(4):193-8. PubMed ID: 11032702
[TBL] [Abstract][Full Text] [Related]
3. Growth hormone (GH) provocative retesting of 108 young adults with childhood-onset GH deficiency and the diagnostic value of insulin-like growth factor I (IGF-I) and IGF-binding protein-3.
Juul A; Kastrup KW; Pedersen SA; Skakkebaek NE
J Clin Endocrinol Metab; 1997 Apr; 82(4):1195-201. PubMed ID: 9100596
[TBL] [Abstract][Full Text] [Related]
4. Safety and efficacy of growth hormone (GH) during extended treatment of adult Japanese patients with GH deficiency (GHD).
Chihara K; Kato Y; Kohno H; Takano K; Tanaka T; Teramoto A; Shimatsu A
Growth Horm IGF Res; 2008 Aug; 18(4):307-17. PubMed ID: 18282776
[TBL] [Abstract][Full Text] [Related]
5. Daily low-dose administration of growth hormone secretagogue stimulates pulsatile growth hormone secretion and elevates plasma insulin-like growth factor-1 levels in pigs.
Malmlöf K; Bauer MK; Johansen PB; Ankersen M; Veldhuis JD
Endocrine; 2001 Dec; 16(3):195-9. PubMed ID: 11954663
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological characterisation of a new oral GH secretagogue, NN703.
Hansen BS; Raun K; Nielsen KK; Johansen PB; Hansen TK; Peschke B; Lau J; Andersen PH; Ankersen M
Eur J Endocrinol; 1999 Aug; 141(2):180-9. PubMed ID: 10427162
[TBL] [Abstract][Full Text] [Related]
7. Oral administration of growth hormone (GH) releasing peptide-mimetic MK-677 stimulates the GH/insulin-like growth factor-I axis in selected GH-deficient adults.
Chapman IM; Pescovitz OH; Murphy G; Treep T; Cerchio KA; Krupa D; Gertz B; Polvino WJ; Skiles EH; Pezzoli SS; Thorner MO
J Clin Endocrinol Metab; 1997 Oct; 82(10):3455-63. PubMed ID: 9329386
[TBL] [Abstract][Full Text] [Related]
8. Bone loss is correlated to the severity of growth hormone deficiency in adult patients with hypopituitarism.
Colao A; Di Somma C; Pivonello R; Loche S; Aimaretti G; Cerbone G; Faggiano A; Corneli G; Ghigo E; Lombardi G
J Clin Endocrinol Metab; 1999 Jun; 84(6):1919-24. PubMed ID: 10372687
[TBL] [Abstract][Full Text] [Related]
9. The pharmacokinetics, pharmacodynamics, safety and tolerability following 7 days daily oral treatment with NN703 in healthy male subjects.
Zdravkovic M; Christiansen T; Eliot L; Agersoe H; Thomsen MS; Falch JF; Søgaard B; Ynddal L; Ilondo MM
Growth Horm IGF Res; 2001 Feb; 11(1):41-8. PubMed ID: 11437473
[TBL] [Abstract][Full Text] [Related]
10. Relationship between the morphological evaluation of the pituitary and the growth hormone (GH) response to GH-releasing hormone Plus arginine in children and adults with congenital hypopituitarism.
Maghnie M; Salati B; Bianchi S; Rallo M; Tinelli C; Autelli M; Aimaretti G; Ghigo E
J Clin Endocrinol Metab; 2001 Apr; 86(4):1574-9. PubMed ID: 11297586
[TBL] [Abstract][Full Text] [Related]
11. The impact of cranial irradiation on GH responsiveness to GHRH plus GH-releasing peptide-6.
Popovic V; Pekic S; Golubicic I; Doknic M; Dieguez C; Casanueva FF
J Clin Endocrinol Metab; 2002 May; 87(5):2095-9. PubMed ID: 11994347
[TBL] [Abstract][Full Text] [Related]
12. Monitoring serum insulin-like growth factor-I (IGF-I), IGF binding protein-3 (IGFBP-3), IGF-I/IGFBP-3 molar ratio and leptin during growth hormone treatment for disordered growth.
Tillmann V; Patel L; Gill MS; Whatmore AJ; Price DA; Kibirige MS; Wales JK; Clayton PE
Clin Endocrinol (Oxf); 2000 Sep; 53(3):329-36. PubMed ID: 10971450
[TBL] [Abstract][Full Text] [Related]
13. Growth hormone (GH) deficiency (GHD) of childhood onset: reassessment of GH status and evaluation of the predictive criteria for permanent GHD in young adults.
Maghnie M; Strigazzi C; Tinelli C; Autelli M; Cisternino M; Loche S; Severi F
J Clin Endocrinol Metab; 1999 Apr; 84(4):1324-8. PubMed ID: 10199773
[TBL] [Abstract][Full Text] [Related]
14. Usefulness of different biochemical markers of the insulin-like growth factor (IGF) family in diagnosing growth hormone excess and deficiency in adults.
Marzullo P; Di Somma C; Pratt KL; Khosravi J; Diamandis A; Lombardi G; Colao A; Rosenfeld RG
J Clin Endocrinol Metab; 2001 Jul; 86(7):3001-8. PubMed ID: 11443159
[TBL] [Abstract][Full Text] [Related]
15. A low starting dose of genotropin in growth hormone-deficient adults.
Janssen YJ; Frölich M; Roelfsema F
J Clin Endocrinol Metab; 1997 Jan; 82(1):129-35. PubMed ID: 8989246
[TBL] [Abstract][Full Text] [Related]
16. Retesting young adults with childhood-onset growth hormone (GH) deficiency with GH-releasing-hormone-plus-arginine test.
Aimaretti G; Baffoni C; Bellone S; Di Vito L; Corneli G; Arvat E; Benso L; Camanni F; Ghigo E
J Clin Endocrinol Metab; 2000 Oct; 85(10):3693-9. PubMed ID: 11061526
[TBL] [Abstract][Full Text] [Related]
17. The GHRH/GHRP-6 test for the diagnosis of GH deficiency in elderly or severely obese men.
Haijma SV; van Dam PS; de Vries WR; Maitimu-Smeele I; Dieguez C; Casanueva FF; Koppeschaar HP
Eur J Endocrinol; 2005 Apr; 152(4):575-80. PubMed ID: 15817913
[TBL] [Abstract][Full Text] [Related]
18. Effects of growth hormone replacement therapy on IGF-related parameters and on the pituitary-gonadal axis in GH-deficient males. A double-blind, placebo-controlled crossover study.
Juul A; Andersson AM; Pedersen SA; Jørgensen JO; Christiansen JS; Groome NP; Skakkebaek NE
Horm Res; 1998; 49(6):269-78. PubMed ID: 9623518
[TBL] [Abstract][Full Text] [Related]
19. Marked GH secretion after ghrelin alone or combined with GH-releasing hormone (GHRH) in obese patients.
Alvarez-Castro P; Isidro ML; Garcia-Buela J; Leal-Cerro A; Broglio F; Tassone F; Ghigo E; Dieguez C; Casanueva FF; Cordido F
Clin Endocrinol (Oxf); 2004 Aug; 61(2):250-5. PubMed ID: 15272922
[TBL] [Abstract][Full Text] [Related]
20. The study of spontaneous GH secretion after 36-h fasting distinguishes between GH-deficient and normal adults.
Aimaretti G; Colao A; Corneli G; Pivonello R; MacCario M; Morrison K; Pflaum CD; Strasburger CJ; Lombardi G; Ghigo E
Clin Endocrinol (Oxf); 1999 Dec; 51(6):771-7. PubMed ID: 10619983
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
